In addition, treatment with LDN-193189, an inhibitor of ALK2/3/6 that suppresses BR-Smad-mediated signaling15, decreased hepatic hepcidin expression in rats and mice with experimentally induced anemia of inflammation16, 17. Here, HAMP is linked to anemia (phenotype).